Skip to search formSkip to main contentSkip to account menu

Stage III Nasopharyngeal Carcinoma

Known as: stage III nasopharynx cancer, Stage III Nasopharyngeal Carcinoma AJCC v7, Nasopharyngeal Cancer, Stage III AJCC v6 
Stage III includes: (T1, N2, M0); (T2, N2, M0); (T3, N0, M0); (T3, N1, M0); (T3, N2, M0). T1: Nasopharyngeal cancer with tumor confined to the… 
National Institutes of Health

Related topics

Related topics

17 relations
Chromosome 13q deletionEpithelial CellsEpitheliumHLA-A gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
RESPONSE OUTCOMES OF CONCURRENT CHEMORADIOTHERAPY (CCRT) FOR STAGE III NASOPHARYNGEAL CARCINOMA
Introduction: Nasopharyngeal carcinoma (NPC) is a rare malignancy with an incidence of 0.5-2 per 100,000 in Europe and the… 
2018
2018
EP-1135: Effects of different treatment and EBV viral load in stage III nasopharyngeal carcinoma patients
2012
2012
Efficacy of clinical stage III nasopharyngeal carcinoma treated by intensity-modulated radiation therapy combined with chemotherapy
Background and purpose:Intensity-modulated radiation therapy(IMRT) enables the delivery of higher radiation dose to the primary… 
2011
2011
Effect of concomitant chemotherapy on prognosis of patients with stage III nasopharyngeal carcinoma after radiotherapy:A retrospective analysis
OBJECTIVE:To evaluate the impacts of chemotherapy combined with radiotherapy on the survival of patients suffered from stage… 
2008
2008
Relationship between the expression of protein p53 or LMP-1 and the prognosis of patients with stage III nasopharyngeal carcinoma
Objective To investigate p53 protein and LMP-1 protein expression in stage Ⅲ nasopharyngeal differentiated non-keratinizing… 
2008
2008
Expressions and significance of hMLH1 and p53 protein with clinical pathological features at stage III nasopharyngeal carcinoma
Objective To investigate the expression of hMLH1 and p53 protein at stageⅢnasopharyngeal poorly dif- ferentiated squamous cell… 
2007
2007
Nursing intervention in patients with stage III nasopharyngeal carcinoma treated by combined radiotherapy and chemotherapy.
Objective To explore the effect of nursing intervention in patients with advanced nasopharyngeal carcinoma treated with combined… 
2005
2005
Concurrent chemoradiotherapy using biweekly cisplatin/tegafur plus uracil/leucovorin in stage III nasopharyngeal carcinoma
5510 Background: Concomitant chemoradiotherapy (CCRT) is considered to be the most effective way to improve overall survival in… 
2001
2001
[Study on the correlation between the expression of protein p53 at stage III nasopharyngeal carcinoma and its biological behavior, prognosis, p53 gene mutation and the expression of LMP-1].
  • S. XuW. Zhang
  • Zhonghua bing li xue za zhi = Chinese journal of…
  • 2001
  • Corpus ID: 31259430
OBJECTIVE To investigate p53 protein expression at stage III nasopharyngeal differentiated non-keratinizing squamous carcinoma… 
1999
1999
[Immunocyte reaction in stage III nasopharyngeal carcinoma in relation to biological findings and prognosis].
OBJECTIVE To study the relationship between macrophages (MP), Langerhans cells (LC), T and B lymphocytes, biological behavior and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)